Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000130

Chairperson & CEO sold 9,500 shares at an average $522.57 ($4,964,376)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

19 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-27 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $135.42 $1,286,490 333,943 I
2026-08-27 Sale : show line 2 in the form 10b5-1 −494 $511.58 $252,718 333,449 I
2026-08-27 Sale : show line 3 in the form 10b5-1 −642 $512.47 $329,007 332,807 I
2026-08-27 Sale : show line 4 in the form 10b5-1 −704 $513.40 $361,434 332,103 I
2026-08-27 Sale : show line 5 in the form 10b5-1 −120 $514.32 $61,718 331,983 I
2026-08-27 Sale : show line 6 in the form 10b5-1 −240 $515.33 $123,679 331,743 I
2026-08-27 Sale : show line 7 in the form 10b5-1 −280 $517.07 $144,780 331,463 I
2026-08-27 Sale : show line 8 in the form 10b5-1 −200 $518.89 $103,779 331,263 I
Open-market sales · 9,500 sh · avg $522.57 · $4,964,376

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-27 Exercise or conversion : show line 20 in the form 10b5-1 Stock Option −9,500 46,910 I
Loading xslF345X06/primarydocument.xml…